MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Feb. 21, 2022 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its fourth quarter 2021 financial results on Thursday, February 24, 2022, before the U.S. financial markets open.
Larry Jasinski, Chief Executive Officer, and Ori Gon, Chief Financial Officer, will host a conference call to discuss the results as follows:
| Time | 8:30 A.M. EST |
| Toll free (U.S.) | (888) 771-4371 |
| International (U.S.) | (847) 585-4405 |
| Germany | 08 00 101 4676 |
| Israel | 18 09 212 582 |
| Access Code | 50284605 |
| Webcast (live and replay) | https://edge.media-server.com/mmc/p/ta4v2yfr under the ‘Investors’ section’. |
The archived webcast will be available via the following link
https://edge.media-server.com/mmc/p/ta4v2yfr
or through the ‘Investors’ section’ on www.rewalk.com.
About ReWalk Robotics Ltd.
ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke. ReWalk’s mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany. For more information on the ReWalk systems, please visit www.rewalk.com.
ReWalk® is a registered trademark of ReWalk Robotics Ltd. in Israel and the Unites States.
Investor Contact:
Ori Gon
Chief Financial Officer
ReWalk Robotics Ltd.
T: +972-4-9590123
E: investorrelations@rewalk.com
PLEASANTON, Calif., Dec. 29, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell…
MESA, Ariz., Dec. 29, 2025 /PRNewswire/ -- Tri-City Cardiology's Ambulatory Surgical Center (ASC), legally referred to…
Collaborative AI-First Ventures Delivers Impactful Solutions for Health, Energy, Small Business and Enterprise SectorsLAS VEGAS,…
$4.1 million upfront with up to approximately $8.3 million of potential additional gross proceeds upon…
Black Book Market Research issues a global operational alert alongside the release of its 2026…
The leader in sports medicine healing innovations worked with athletes, athletic trainers, physicians and foundations…